Diversion Control Division, US Department of Justice, Drug Enforcement Administration

RESOURCES > Federal Register Notices > Manufacturers Notice of Application - 2021 > Sigma Aldrich Research Biochemicals, Inc.

Manufacturers Notice of Application - 2021

[Federal Register Volume 86, Number 35 (Wednesday, February 24, 2021)]
[Pages 11329-11330]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-03760]


Drug Enforcement Administration

[Docket No. DEA-770]

Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

SUMMARY: Sigma Aldrich Research Biochemicals, Inc, has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 26, 2021. Such persons may also file a written request for a hearing on the application on or before April 26, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on December 17, 2020, Sigma Aldrich Research Biochemicals, Inc., 400-600 Summit Drive, Burlington, Massachusetts 01803, applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:

Controlled Substance Drug Code Schedule
Cathinone 1235 I
4-Methyl-N-Methylcathinone 1248 I
Methaqualone 2565 I
JWH-018 & AM678 7118 I
Lysergic Acid Diethylamide 7315 I
Tetrahydrocannabinols 7370 I
Mescaline 7381 I
3,4-Methylenedioxymethamphetamine 7405 I
Alpha-Methyltryptamine 7432 I
Dimethyltryptamine 7435 I
5-Methoxy-N,N-Diisopropyltryptamine 7439 I
1-Benzylpiperazine 7493 I
2-(2,5-Dimethoxyphenyl) Ethanamine 7517 I
3,4-Methylenedioxypyrovalerone 7535 I
3,4-Methylenedioxy-N-Methylcathinone 7540 I
Heroin 9200 I
Normorphine 9313 I
Norlevorphanol 9634 I
Amphetamine 1100 II
Methylphenidate 1724 II
Nabilone 7379 II
Phencyclidine 7471 II
Cocaine 9041 II
Codeine 9050 II
Ecgonine 9180 II
Levorphanol 9220 II
Meperidine 9230 II
Methadone 9250 II
Morphine 9300 II
Thebaine 9333 II
Levo-Alphacetylmethadol (LAAM) 9648 II
Noroxymorphone 9668 II
Remifentanil 9739 II
Sufentanil 9740 II
Carfentanil 9743 II
Fentanyl 9801 II

[[Page 11330]]

The company plans to manufacture reference standards.

William T. McDermott,
Assistant Administrator.

[FR Doc. 2021-03760 Filed 2-23-21; 8:45 am]


NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).

Emergency Disaster Relief
Search for Year Round Pharmaceutical Disposal Locations.
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility